(Q37550053)

21 August 2017

1 reference

title

Catheter thrombosis and percutaneous coronary intervention: fundamental perspectives on blood, artificial surfaces and antithrombotic drugs (English)

1 reference

21 August 2017

0 references

0 references

4

Robert A Harrington

1 reference

21 August 2017

2

Jeffrey I Weitz

1 reference

21 August 2017

3

Yahye Merhi

1 reference

21 August 2017

Mark Y Chan

1

1 reference

21 August 2017

Richard C Becker

series ordinal

5

1 reference

21 August 2017

publication date

1 October 2009

1 reference

Journal of Thrombosis and Thrombolysis

21 August 2017

published in

1 reference

21 August 2017

volume

28

1 reference

21 August 2017

issue

3

1 reference

21 August 2017

page(s)

366-380

1 reference

https://scigraph.springernature.com/pub.10.1007/s11239-009-0375-6

21 August 2017

exact match

0 references

cites work

Reduction of the surgical complication rate by the use of a hypothrombogenic catheter coating.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0375-6

Influence of stent expansion states on platelet deposition in an extracorporeal porcine arteriovenous shunt model using a multichannel perfusion chamber

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0375-6

Guide wire thrombogenicity measured by fibrinopeptide A radioimmunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0375-6

Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0375-6

A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0375-6

Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention

21 January 2018

1 reference

12 December 2020

Acute thrombogenicity of intact and injured natural blood conduits versus synthetic conduits: neutrophil, platelet, and fibrin(ogen) adsorption under various shear-rate conditions

1 reference

12 December 2020

Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomize

1 reference

12 December 2020

Transmission of a procoagulant signal from tissue factor-bearing cell to platelets

1 reference

12 December 2020

Interfacial energetics of blood plasma and serum adsorption to a hydrophobic self-assembled monolayer surface.

1 reference

12 December 2020

Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1,000 cases

1 reference

12 December 2020

Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin

1 reference

12 December 2020

An extensive interaction interface between thrombin and factor V is required for factor V activation

1 reference

12 December 2020

Increased vascular wall thrombogenicity combined with reduced blood flow promotes occlusive thrombus formation in rabbit femoral artery.

1 reference

12 December 2020

Levels of expression of P-selectin, E-selectin, and intercellular adhesion molecule-1 in coronary atherectomy specimens from patients with stable and unstable angina pectoris

1 reference

12 December 2020

Intrinsic pathway of coagulation and arterial thrombosis

1 reference

12 December 2020

Comparison of fondaparinux, low molecular-weight heparin and unfractionated heparin in preventing thrombus formation on mechanical heart valves: results of an in-vitro study.

1 reference

12 December 2020

A randomized trial comparing the impact of a nonionic (Iomeprol) versus an ionic (Ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty

1 reference

12 December 2020

Tissue factor pathway inhibitor, natural coagulation inhibitors and hemostatic activation markers in patients with acute coronary syndromes

1 reference

12 December 2020

Platelet adhesion onto artificial surfaces: inhibition by benzamidine, pentamidine, and pyridoxal-5-phosphate as demonstrated by flow cytometric quantification of platelet adhesion to microspheres

1 reference

12 December 2020

Antithrombotic effects of factor Xa inhibition with DU-176b: Phase-I study of an oral, direct factor Xa inhibitor using an ex-vivo flow chamber

1 reference

12 December 2020

A new in vitro model to study interaction between whole blood and biomaterials. Studies of platelet and coagulation activation and the effect of aspirin

1 reference

12 December 2020

A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial

1 reference

12 December 2020

Cerebral infarction: incidence and risk factors after diagnostic and interventional cardiac catheterization--prospective evaluation at diffusion-weighted MR imaging

1 reference

12 December 2020

Arterial Thrombus Formation During Clinical Percutaneous Catheterization

1 reference

12 December 2020

Thrombogenicity of guide wires

1 reference

12 December 2020

A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation

1 reference

12 December 2020

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial

1 reference

12 December 2020

Acute occlusion of the left subclavian artery with artery dissection.

1 reference

12 December 2020

Early ambulation and variability in anticoagulation during elective coronary stenting with a single intravenous bolus of low-dose, low-molecular weight heparin enoxaparin

1 reference

12 December 2020

Contact activation during incubation of five different polyurethanes or glass in plasma

1 reference

12 December 2020

New antithrombotic drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

1 reference

12 December 2020

Comparison of fondaparinux and enoxaparin in acute coronary syndromes

1 reference

12 December 2020

Atherothrombosis at a distance: contributing role of existing large-burden vascular disease, circulating biosignals and modulating extravascular tissues

1 reference

12 December 2020

The CIAO (Coronary Interventions Antiplatelet-based Only) Study: a randomized study comparing standard anticoagulation regimen to absence of anticoagulation for elective percutaneous coronary intervention.

1 reference

12 December 2020

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

1 reference

12 December 2020

Reduced thrombogenic characteristics of expanded polytetrafluoroethylene and polyurethane arterial grafts after heparin bonding

1 reference

12 December 2020

The scientific community's quest to identify optimal targets for anticoagulant pharmacotherapy

1 reference

12 December 2020

Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty

1 reference

12 December 2020

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

1 reference

12 December 2020

Reduction of monocyte-platelet interaction and monocyte activation in patients receiving antiplatelet therapy after coronary stent implantation

1 reference

12 December 2020

Immobilization of poly(ethylene glycol) onto a poly(vinyl alcohol) hydrogel: 2. Evaluation of thrombogenicity

1 reference

12 December 2020

Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes

1 reference

12 December 2020

Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes

1 reference

12 December 2020

Studies in intravascular coagulation. I. Coagulation changes in isolated venous segments

1 reference

12 December 2020

Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease?

1 reference

12 December 2020

Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial

1 reference

12 December 2020

Thrombogenicity of arterial catheters and guidewires

1 reference

12 December 2020

Bivalirudin during primary PCI in acute myocardial infarction

1 reference

12 December 2020

The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding

1 reference

12 December 2020

A cell-based model of hemostasis

1 reference

12 December 2020

Platelet receptors for the complement component C1q: implications for hemostasis and thrombosis

1 reference

12 December 2020

Elective percutaneous coronary intervention using broad-spectrum antiplatelet therapy (eptifibatide, clopidogrel, and aspirin) alone, without scheduled unfractionated heparin or other antithrombin therapy

1 reference

12 December 2020

Factor XII fragment and kallikrein generation in plasma during incubation with biomaterials

1 reference

12 December 2020

The effect of factor X level on thrombin generation and the procoagulant effect of activated factor VII in a cell-based model of coagulation

1 reference

12 December 2020

Shear-induced platelet aggregation

1 reference

12 December 2020

In vivo thrombus formation in murine models

1 reference

12 December 2020

Bivalirudin for patients with acute coronary syndromes

1 reference

12 December 2020

Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial

1 reference

12 December 2020

Epinephrine and shear stress synergistically induce platelet aggregation via a mechanism that partially bypasses VWF-GP IB interactions

1 reference

12 December 2020

Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass

1 reference

12 December 2020

Cardiopulmonary bypass induces leukocyte-platelet adhesion

1 reference

12 December 2020

Relations of abnormal and injury electric potential differences to intravascular thrombosis

1 reference

12 December 2020

Nitinol versus stainless steel stents: acute thrombogenicity study in an ex vivo porcine model.

1 reference

12 December 2020

Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis

1 reference

12 December 2020

In-vitro comparison of fondaparinux, unfractionated heparin, and enoxaparin in preventing cardiac catheter-associated thrombus

1 reference

12 December 2020

Thrombogenicity of hydrophilic and nonhydrophilic microcatheters and guiding catheters

1 reference

12 December 2020

What does it take to make the perfect clot?

1 reference

12 December 2020

Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets

1 reference

12 December 2020

Efficacy and safety of triple antiplatelet therapy with and without concomitant anticoagulation during elective percutaneous coronary intervention (the REMOVE trial)

1 reference

12 December 2020

Randomized, double-blind, dose-ranging study of otamixaban, a novel, parenteral, short-acting direct factor Xa inhibitor, in percutaneous coronary intervention: the SEPIA-PCI trial

1 reference

12 December 2020

Initiation and propagation of blood coagulation at artificial surfaces studied in a capillary flow reactor

1 reference

12 December 2020

Bivalirudin versus unfractionated heparin during percutaneous coronary intervention

1 reference

12 December 2020

The mechanisms of coronary restenosis: insights from experimental models

1 reference

12 December 2020

Comparison of bivalirudin, enoxaparin, and unfractionated heparin in preventing cardiac catheter thrombosis. Results of an in-vitro study

1 reference

12 December 2020

Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial

1 reference

12 December 2020

Kallikrein activates prothrombin

1 reference

12 December 2020

Update on acute coronary syndromes and implications for therapy

1 reference

12 December 2020

Activation of the complement system at the interface between blood and artificial surfaces

1 reference

12 December 2020

Identification of proteins adsorbed to hemodialyser membranes from heparinized plasma

1 reference

12 December 2020

2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evide

1 reference

12 December 2020

Heparin for coronary angioplasty: high dose, low dose, or no dose?

1 reference

12 December 2020

Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention

1 reference

12 December 2020

10.1007/S11239-009-0375-6

Identifiers

DOI

1 reference

21 August 2017

1 reference